You are here: / Industry Press Releases

One revolutionary system offers superior protein yields, consistent results, a streamlined workflow and scales from discovery to production CARLSBAD, Calif., May 2, 2018 /PRNewswire/ — Historically, undefined insect media components such as yeastolate have made it challenging to achieve consistent results and protein yields across multiple experiments. These factors can significantly slow vaccine development at a time when manufacturers are under pressure to develop vaccines faster and more efficiently. Focused on removing barriers to vaccine development and production, Thermo Fisher Scientific announced today its Gibco ExpiSf system, the first-ever chemically defined insect protein expression system. The revolutionary ExpiSf system brings together the company’s Gibco media technology, Lipofectamine transfection technology and molecular biology expertise to deliver three times more protein and consistent results. Unlike other systems, ExpiSf has been optimized for the generation of high-quality baculovirus using a suspension-based transfection protocol that delivers protein in half the time compared to traditional insect platforms. The superior performance enables customers to realize significant time savings without sacrificing quality and reproducibility across experiments. “The new ExpiSf Expression System offers a convenient virus generation and protein expression cell line in only two steps, for both secreted and intracellular proteins,” commented Xuan Droz, Ph.D., project leader, Redbiotec AG. “We predict that using the ExpiSf system will save us about 30 percent in the time taken for protein expression and make cell maintenance simpler.” Available now, ExpiSf has many advantages over alternative insect expression platforms: > 300 percent higher protein yield: In performance tests against five competing insect media, the ExpiSf System demonstrated greater protein expression – delivering 3x more protein. Consistent results: Chemically defined, animal-origin free, yeastolate-free growth medium supports consistent cell growth and protein expression, run after run. One optimized system: Fully-integrated platform removes the need to optimize individual components, saving time and cost. Streamlined workflow: The ExpiSf system simplifies baculovirus production to deliver protein in half the time, 6-10 days, compared to 10-20 days via classical techniques. Scales from discovery to production: The scalability of ExpiSf system accelerates development by delivering equivalent cell growth and protein volumetric yield from small to large scale, making the system well-suited for both discovering new therapies and producing them in large quantities. “The ExpiSf Expression System is the newest member of the Expi family delivering superior protein expression and consistent performance in Sf9 cells,” commented Amy Butler, vice president and general manager, Cell Biology at Thermo Fisher Scientific. “ExpiSf is the first-ever chemically defined insect expression system that enables our customers to streamline vaccine development from the bench to the clinic. The system is also suitable for applications in basic research where protein structure and/or function is being studied, for example, in structural biology.” ExpiSf System Components ExpiSf Expression System Starter Kit – Includes all of the reagents necessary to generate recombinant baculovirus and express proteins with the system. The ExpiSf system, related products and training course are available to order at www.thermofisher.com/expisf ExpiSf CD Medium – A GMP-manufactured, chemically defined, yeastolate-free, animal origin-free (AOF) high-density insect growth medium. ExpiSf9 Cells – ExpiSf9 is a robust cell line derived from Sf9 cells and adapted for high-density suspension culture in ExpiSf CD Medium. ExpiSf Enhancer – A chemically defined protein expression enhancer that is specifically matched to ExpiSf CD Medium to deliver significantly higher protein yields. ExpiFectamine Sf Transfection Reagent – a next-generation cationic lipid-based reagent for efficient transfection of DNA from insect cells using a faster, simpler protocol than alternative options. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

May 2, 2018

One revolutionary system offers superior protein yields, consistent results, a streamlined workflow and scales from discovery to production  CARLSBAD, Calif. -- Historically, undefined insect media components such as yeastolate have made it challenging to achieve consistent results and protein yields across multiple experiments. These factors can significantly slow vaccine development at a time when manufacturers are under [...]

Jenway launches new, highly accurate micro-volume spectrophotometer

May 2, 2018

Cole-Parmer Ltd announced today that Jenway, a leading UK manufacturer of analytical laboratory instruments, is launching its new micro-volume spectrophotometer, the 7415 Nano. This announcement follows the showcase of the 7415 Nano at ArabLab 2018, a 4-day event held at the Dubai International Convention & Exhibition Centre, and one of the largest international trade fairs [...]

Shimadzu Scientific Instruments Partners With the University of North Florida in Creating the Materials Science and Engineering Research FacilityShimadzu Scientific Instruments Partners With the University of North Florida in Creating the Materials Science and Engineering Research Facility

May 2, 2018

COLUMBIA, Md.  — Shimadzu Scientific Instruments (SSI) and the University of North Florida (UNF) have joined forces to help establish the Materials Science and Engineering Research Facility (MSERF) on the campus of UNF in Jacksonville, Fla. MSERF, which opened its doors in July 2017, is a facility designed to support education and research efforts across all [...]

Bio-Rad Expedites Disease Biomarker Discovery and Drug Development with the Launch of Bio-Plex Pro Human Cytokine Screening Panel

May 2, 2018

The Immunoassay is the Market’s First Validated High-Performance Multiplex Screening Panel The Bio-Plex Pro Human Cytokine Screening Panel is a multiplex assay that can accurately and reproducibly quantify up to 48 analytes involved in complex biological networks in a single assay. HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex [...]

Raman Bhatnagar is appointed new CEO at CAMO Software

May 2, 2018

Benefiting from an established pedigree the company already has the knowledge, customers and products in place and now the time is right for further expansion in the field of industrial data analytics and predictive science. Oslo, Norway – CAMO Software AS today appointed Raman Bhatnagar as the company’s new Chief Executive Officer. Raman is an [...]

BIOSERA and Alliance Global Group sign an exclusive distribution agreement

May 1, 2018

Dubai BIOSERA (France) signed an exclusive distribution agreement with Alliance Global to bring their highest quality serum portfolio to AGBL’s market. “BIOWEST’s diverse serum and cell culture media products will complement the AGBL Cell Biology range of products and support our customers in academia, governmental and industrials markets.” said Fatima Kakal, Product Manager Cell and [...]

Phenomenex Announces Direct Sales and Support in Singapore

May 1, 2018

Torrance, Calif. – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that it will begin to directly serve customers in Singapore, effective May 1, 2018. Direct presence in Singapore will allow Phenomenex to provide customers with a variety of services such as access to [...]

Agilent Announces Real-Time, Live-Cell ATP Rate Assay Kit

May 1, 2018

New Assay Expands Application Range of Agilent Seahorse XF Technology SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the Agilent Seahorse XF Real-Time ATP Rate Assay Kit, a new product that will enable biologists to enhance their understanding of how live-cells function in real-time. The Seahorse XF Real-Time ATP Rate Assay Kit enables [...]

Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

May 1, 2018

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs CARLSBAD, Calif. -- Thermo Fisher Scientific announced today it has signed new agreements with Daiichi Sankyo and Takeda Pharmaceuticals designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs at each of the firms. [...]

LGC acquires BioAutomation Corporation

May 1, 2018

LGC has today announced a further strengthening of its nucleic acid chemistry (NAC) offering with the acquisition of BioAutomation Corporation (BioAutomation), manufacturer of the renowned MerMade oligo synthesis instruments. This investment follows LGC’s acquisitions of Biosearch, Prime Synthesis and LINK Technologies, and will drive further growth in the oligonucleotide reagent and synthesised oligonucleotides markets. Brian Kim, President and Managing [...]

Access IBO on Knowledge Center